BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38286882)

  • 41. ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Dietz MV; Madsen EVE
    Ann Surg Oncol; 2022 Oct; 29(11):6577-6578. PubMed ID: 35486267
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.
    Behrenbruch C; Hollande F; Thomson B; Michael M; Warrier SK; Lynch C; Heriot A
    ANZ J Surg; 2017 Sep; 87(9):665-670. PubMed ID: 28664645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Ahmed S; Levine EA; Randle RW; Swett KR; Shen P; Stewart JH; Votanopoulos KI
    Ann Surg Oncol; 2014 Dec; 21(13):4226-31. PubMed ID: 25034815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.
    Newhook TE; Agnes A; Blum M; Estrella JS; Das P; Ho L; Ajani JA; Minsky BD; Mansfield P; Badgwell BD
    Ann Surg Oncol; 2019 May; 26(5):1394-1400. PubMed ID: 30680477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'.
    Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F;
    Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
    Samel S; Singal A; Becker H; Post S
    Eur J Surg Oncol; 2000 Apr; 26(3):222-6. PubMed ID: 10753533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.
    Votanopoulos KI; Russell G; Randle RW; Shen P; Stewart JH; Levine EA
    Ann Surg Oncol; 2015 Apr; 22(4):1274-9. PubMed ID: 25319583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
    Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
    J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
    Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
    Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Acs M; Gerken M; Zustin J; Blaj S; Isgandarova S; Piso P
    J Surg Res; 2023 Mar; 283():839-852. PubMed ID: 36915011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages.
    Zhang JF; Lv L; Zhao S; Zhou Q; Jiang CG
    Ann Surg Oncol; 2022 May; 29(5):3170-3186. PubMed ID: 35175455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat peritoneal carcinomatosis from gastric cancer: a clinical study of 110 patients].
    Ji ZH; Li XB; Liu G; Yu Y; Lin YL; Zhang YB; Li Y
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(38):3079-3083. PubMed ID: 30392267
    [No Abstract]   [Full Text] [Related]  

  • 54. HIPEC with CRS versus cytoreductive surgery (CRS) for the gastric cancer metastasis to peritoneum.
    Chen Z; Ali M; Kai Z; Wang Y; Wang C
    Clin Transl Oncol; 2023 Apr; 25(4):1011-1016. PubMed ID: 36401054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIPEC and CRS in peritoneal metastatic gastric cancer - who really benefits?
    Hotopp T
    Surg Oncol; 2019 Mar; 28():159-166. PubMed ID: 30851894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.
    Glehen O; Gilly FN; Arvieux C; Cotte E; Boutitie F; Mansvelt B; Bereder JM; Lorimier G; Quenet F; Elias D;
    Ann Surg Oncol; 2010 Sep; 17(9):2370-7. PubMed ID: 20336386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
    Yang XJ; Li Y; Yonemura Y
    J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials.
    Deng H; Li B; Qin X
    Updates Surg; 2022 Dec; 74(6):1805-1816. PubMed ID: 36116077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
    Bhagwandin SB; Salti GI
    Tumori; 2015 Mar; 101(1):e1-3. PubMed ID: 25702649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.